Ethics and dilemmas regarding acceptance of COVID-19 vaccine among people living in an Indian metropolitan city during the pandemic: a qualitative study Authors: Jeffrey Pradeep Raj, Sowntappan Balasubramanian, Shilpa Nellikal, Dattaprasad Avinash Sawant, Deepika Sadawarte Published: 2025 ABSTRACT Abstract AbstractObjectivesTo explore public perceptions of COVID-19 vaccine acceptance and hesitancy in India, and to identify underlying factors influencing attitudes toward vaccination during the second wave of the pandemic.DesignA cross-sectional qualitative study based on a grounded theory approach.SettingCommunity-based interviews conducted in Mumbai, a densely populated metropolitan city in India, during the second COVID-19 wave (April–June 2021).ParticipantsTwenty purposively selected adults (men and women aged 22–87 years) from varied educational and occupational backgrounds. Inclusion criteria were willingness to participate and the ability to provide informed consent; individuals directly involved in COVID-19 vaccine policy or administration were excluded.MethodsIn-depth semi-structured interviews were conducted using an interview guide exploring perceptions of COVID-19 vaccination. Interviews were audio-recorded, transcribed verbatim and analysed inductively following grounded theory principles. Reflexivity was maintained throughout data collection and analysis.Primary and secondary outcome measuresKey emergent themes relating to vaccine acceptance, hesitancy and influencing factors such as safety concerns, efficacy perceptions, media influence and social determinants of vaccine choice.ResultsAttitudes toward vaccination ranged from strong acceptance to hesitancy driven by concerns about safety, side effects and the speed of vaccine development. Media coverage, peer and healthcare professional opinions, and personal experiences shaped the decision of the participants. Cost considerations and lack of vaccine choice influenced uptake. Many participants favoured vaccination being voluntary rather than mandatory for the general population.ConclusionTrust in authorities, transparent risk communication and culturally sensitive engagement are critical to improving vaccine confidence. Public health strategies should address safety concerns, ensure equitable access and promote consistent messaging to enhance vaccine acceptance in current and future pandemic contexts.Keywords: COVID-19, Public health, QUALITATIVE RESEARCH, Health Services Accessibility STRENGTHS AND LIMITATIONS OF THIS STUDY Conducted during the highly devastating second COVID-19 wave in India, capturing public sentiment at a critical time. Conducted during the highly devastating second COVID-19 wave in India, capturing public sentiment at a critical time. Addressed real-time concerns like vaccine trust, safety fears and misinformation. Addressed real-time concerns like vaccine trust, safety fears and misinformation. Offers insightful qualitative data on public attitudes in Mumbai, India, during a health crisis. Offers insightful qualitative data on public attitudes in Mumbai, India, during a health crisis. Subject to biases inherent in qualitative research, such as researcher subjectivity and self-reporting. Subject to biases inherent in qualitative research, such as researcher subjectivity and self-reporting. Focused only on the general public, limiting relevance to healthcare workers or other stakeholder groups. Focused only on the general public, limiting relevance to healthcare workers or other stakeholder groups. Introduction The COVID-19 pandemic, caused by the SARS-CoV-2 virus, with the first cases reported in Wuhan, China, quickly spread to multiple countries,1 2 leading the WHO to declare it a pandemic on 12 March 2020.3 As the global crisis worsened and thousands succumbed to the disease, the focus shifted to finding effective treatments and prevention methods. This urgency led to a concerted global effort to develop safe and efficient COVID-19 vaccines.4 India reported its first confirmed COVID-19 case in January 2020, followed by a nationwide lockdown in March 2020 during the first wave of the pandemic. Case numbers declined by late 2020 but surged again during the second wave (April–June 2021), driven largely by the Delta variant and associated with higher transmissibility and mortality. The vaccination campaign began in January 2021, initially prioritising healthcare workers, frontline workers, older adults and vulnerable populations. During this phase, vaccines were supplied and administered free of cost at both government and designated private healthcare facilities. As the programme expanded, private hospitals were later permitted to procure vaccines directly from manufacturers and offer them on a paid basis, primarily to enhance accessibility and reduce the burden on government centres.5 This dual model aimed to improve accessibility and reduce crowding at public vaccination sites, though the introduction of a cost component contributed to public concerns about affordability and equity. Despite all efforts, vaccine uptake was not as high as anticipated, and several reasons were speculated for the vaccine hesitancy, including the recent media reports of adverse effects ranging from common reactions such as fever and body pain to rare or sensationalised events, which fuelled public fear, along with concerns about the level and duration of immune protection offered by the newly developed vaccines.6 7 When the vaccine was believed to bring about the long-awaited herd immunity, the occurrence of serious adverse events may have significantly contributed to public hesitation about whether to proceed with vaccination or not.8 COVID-19 vaccination in India was voluntary, but strongly recommended at the national level, with the Ministry of Health and Family Welfare emphasising that individuals could choose whether to be vaccinated. However, some state governments and private institutions introduced temporary restrictions or incentives—such as requiring vaccination for workplace entry, travel or public events—which created public ambiguity about whether vaccination was de facto mandatory.9 These mixed signals, combined with the introduction of paid vaccines in private facilities, contributed to perceptions of inequity and hesitancy among certain groups. Additionally, ethical dilemmas arose regarding the development of COVID-19 vaccines and proposed mass vaccination strategies. The primary ethical discussions surrounding vaccine regulation, development and usage generally centred on (1) mandates, (2) research and testing, (3) informed consent and (4) access inequalities.10 At the time of this study, uncertainty loomed over whether the Indian Government would enforce COVID-19 vaccination for all. Concerns arose regarding the adequacy of research and testing preceding mass vaccinations, given emergency marketing authorisations. Mandated vaccination raised issues about adverse event management and costs. Consequently, the initial vaccination uptake in India was low, and the impact of the second COVID-19 wave was devastating.5 Despite a government-provided booster dose, uptake remained poor.11 These debates reflected broader ethical questions on the balance between collective responsibility and individual autonomy, fairness in vaccine distribution, and public trust in regulatory and health systems. The speed of vaccine approval and rollout amplified concerns about transparency and accountability, while socioeconomic disparities heightened perceptions of inequity in access and choice. Such complex moral considerations shaped public discourse and personal decision-making around vaccination. Recognising these dimensions, the study adopted a qualitative approach to capture how individuals understood, rationalised and negotiated these ethical tensions within their lived experiences. Therefore, our study explored dilemmas surrounding vaccine acceptance with the aim of providing insights to help health authorities address public concerns during future epidemics and pandemics, particularly in low-income and middle-income country (LMIC) settings. Methods Ethics The study obtained approval from the Institutional Ethics Committee III – Seth GS Medical College and King Edward Memorial Hospital, under reference number EC/OA-20/2021, dated 3 March 2021. Prior to enrolment, all potential participants provided written informed consent. The research complied with the Good Clinical Practice principles as outlined in the Declaration of Helsinki (World Medical Association, Fortaleza, 2013) and followed the National Guidelines for Ethical Research in Human Participants (Indian Council of Medical Research guidelines, 2017). Study design and setting This was a cross-sectional qualitative study with a grounded theory approach to elicit the reasons behind COVID-19 vaccine acceptance/hesitancy. In-depth interviews were conducted over a 3-month period from April 2021 to June 2021. This corresponded to the second COVID-19 wave in India. The second wave hit harder in many ways: symptoms were worse, inflammatory markers spiked, imaging results were more alarming, complications increased, more people needed ventilators, and sadly, more lives were lost.12 The study was conducted in Mumbai, one of the most densely populated metropolitan regions of India, which experienced an early surge of cases during the first wave in mid 2020 and a sharper, more severe second wave between April and May 2021. During this period, the city reported high test-positivity rates and healthcare strain. Participant eligibility criteria and sampling method Consenting adult participants of any sex, age 18 years and above, were approached. Healthcare workers, those involved in clinical research and those who participated in COVID-19 vaccine clinical trials were excluded. A non-random purposive sampling approach was used to identify potential participants representing different ages, sexes, educational levels and occupations, to capture a broad range of perspectives on vaccine acceptance and hesitancy. Recruitment was conducted through community and professional networks and continued until no new insights emerged from additional interviews. Study procedures All in-depth interviews were conducted in a face-to-face manner after obtaining a written informed consent. They were conducted at a place of convenience for the participant (home/workplace) in a separate room with closed doors where only the interviewer(s) and the interviewee were present, thus maintaining privacy. All interviews adhered to institutional and governmental safety guidelines: both interviewer and participant wore masks throughout, physical distancing was maintained, and hand hygiene was ensured before and after each session. Interviews were conducted in well-ventilated rooms or open spaces to minimise risk. The participant information sheet and consent form clearly outlined these precautions, and participants verbally reconfirmed their comfort with in-person interaction before beginning. Although the option of remote or telephonic interviews was explored during study planning, it was deemed unsuitable due to limited digital access among the target population and the need to capture contextual nuances essential to qualitative inquiry. Interviews were conducted in English, Hindi or Marathi as per the preference of the participant. A semi-structured pilot-tested interview guide (online supplemental file 1), along with their translations translated by professional translators, was made available for the interviewer. The interview guide had questions pertaining to the vaccine acceptance in general and specific to COVID-19, safety, effectiveness and the perceived economic impact of COVID-19 vaccines, ethical conduct of clinical trials and views on COVID-19 vaccination policy decisions by the Government of India. However, this interview guide was a dynamic document and incorporated changes based on prior interviews or evolving conversation with the current participant. All interviews were audio recorded with consent and later transcribed and translated (if applicable) by the study team. The transcripts were not returned to participants for verification, as perspectives on vaccination were evolving rapidly during the pandemic. A participant checking at a later time could have altered the contemporaneous meaning of responses, given that the attitudes of participants often shifted with changes in case numbers, vaccine availability and media narratives. Field notes documenting contextual observations, non-verbal cues and reflexive impressions were taken by the interviewer themselves. Research team The research team comprised five physicians (three resident doctors pursuing their post-graduation and two faculty members) practising allopathic medicine and involved in the care of COVID-19 patients first-hand. One each of the resident doctor and the faculty was female and the rest male. The team comprised native speakers of Hindi and Marathi. All investigators and their household members had completed their primary series of COVID-19 vaccinations without experiencing any serious adverse events. Data analysis Data analysis was conducted following the principles of grounded theory,13 involving a systematic and iterative process of coding, categorising and conceptualising the data. The analysis aimed to explore the perceptions of the general public regarding the COVID-19 vaccine development, testing and vaccination policies during the COVID-19 pandemic and to develop a theoretical understanding of their decision-making. The transcripts were initially coded by one coder using open coding, where concepts and themes were identified without preconceived categories. Through axial coding, relationships between categories were explored to develop a theoretical framework. The process of data analysis continued until theoretical saturation was reached, meaning that no new categories or concepts emerged from the data. Saturation was achieved after analysing data from 20 participants, suggesting that the themes and patterns identified were comprehensive and representative of the experiences of non-healthcare workers during the pandemic. Several key themes emerged from the analysis. Quotes and excerpts from interviews of participants were used to illustrate each theme and provide context for the findings. Throughout the analysis process, personal biases and assumptions were documented in memos to maintain researcher reflexivity. Reflexive journaling allowed for critical reflection on the role of the researcher in shaping the analysis and interpreting the data. Patient or public involvement Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research. Results A total of 24 participants were approached, of whom 4 refused consent and 20 were enrolled. Their individual demographic characteristics are summarised in table 1. Given the qualitative nature of this study and the grounded theory approach, terms such as ‘some’, ‘several’ or ‘many’ are used to convey the relative prominence of views, rather than precise numerical proportions, which were not the focus of our analytical framework. Table 1Demographic characteristics of study participantsIDAge group (years)SexEducationOccupationDiagnosed with COVID-19 in the pastCOVID-19 vaccination received?120–29MaleBachelor’sBusinessYesNo280–89MaleSecondary or belowProfessional/serviceNoYes350–59FemaleBachelor’sHomemaker/retiredNoYes440–49MaleBachelor’sProfessional/serviceNoYes520–29FemaleBachelor’sProfessional/serviceNoNo680–89FemaleSecondary or belowHomemaker/retiredNoYes720–29FemaleBachelor’sProfessional/serviceNoYes820–29MaleBachelor’sBusinessNoNo920–29MaleBachelor’sBusinessNoNo1050–59FemaleMaster’s/doctoralProfessional/serviceNoYes1130–39MaleSecondary or belowProfessional/serviceNoNo1260–69FemaleSecondary or belowHomemaker/retiredNoYes1330–39FemaleBachelor’sProfessional/serviceYesNo1420–29FemaleMaster’s/doctoralProfessional/serviceNoNo1520–29FemaleBachelor’sProfessional/serviceNoYes1660–69MaleBachelor’sBusinessNoYes1730–39MaleBachelor’sProfessional/serviceNoNo1820–29FemaleBachelor’sProfessional/serviceNoNo1950–59FemaleMaster’s/doctoralHomemaker/retiredNoNo2060–69MaleMaster’s/doctoralHomemaker/retiredNoYes Demographic characteristics of study participants Theme 1: vaccination acceptance Under this theme, the attitudes of participants toward COVID-19 and general vaccines were categorised into four groups: ‘accepts COVID-19 vaccine’, ‘ambiguous’, ‘favours vaccine (general)’, and ‘does not favour COVID-19 vaccine’. Most participants expressed positive views on vaccines in general. With the emergence of the COVID-19 pandemic and global panic, the introduction of COVID-19 vaccines was seen as a boon. I will definitely take the vaccine. (P13) I am going to take the vaccine. (P9) However, while some participants expressed uncertainty—often linked to the rapid development timeline—one participant expressed particularly strong scepticism and distrust towards the COVID-19 vaccine. I'm not sure how safe it is since it’s new. I think it’s risky for me to get vaccinated immediately after development. (P1) My first thought to the COVID vaccine is a strict no. (P8) Although opinions differed about the COVID-19 vaccine, many participants expressed generally favourable views toward vaccination in general, citing trust in established vaccines like Bacille Calmette–Guérin (BCG) and polio, which have been tested over time. Vaccinations help us in the longer term. (P1) It’s necessary to prevent certain diseases. (P10) I'm fully pro-vaccination. Vaccines are meant to save lives. (P11) Theme 2: vaccination experience This theme explored the different perspectives on COVID-19 vaccination based on the own experiences of participants or those of others, which were broadly characterised as either ‘fearful’ or ‘painful’. Adverse reactions reported by others instilled fear in many participants, influencing their decision to get vaccinated, and peer experiences played a crucial role in shaping opinions about vaccines. Some people said they had reactions, so won’t take it. (P13) My friend’s mother had side effects. (P11) In some cases, negative memories from past vaccinations, such as pain from injections, influenced opinions about COVID-19 vaccines. I remember my polio vaccine; it was painful. (P11) Theme 3: role of media in COVID-19 vaccination Social media and news channels had a significant impact on shaping opinions. Some considered that the entire situation was exaggerated. So what I feel there is a COVID-19 but not to the extent the media is showing. (P8) Facebook, Instagram, memes, the Internet, television and newspapers were named as sources of information besides friends and healthcare workers. Theme 4: adverse events due to COVID-19 vaccines Although many were aware of the common side effects like fever, fatigue, headache, muscle/body pain, diarrhoea, vomiting and pain or redness at the injection site, a small number of participants lacked awareness. I don’t really have information, as my memory serves. I don’t know the side-effects. I have never had them. (P11) Theme 5: motivators and demotivators for COVID-19 vaccination The categories under this theme were ‘clear communication’, ‘convinced by doctor and friend’, ‘peers and social media exposure’, ‘politician’ and ‘television celebrity’. If any doctor like friend doctor of mine convinces me like it is good for you, then I will. (P1) The demotivators that were mentioned were ‘insufficient information’, ‘lack of clarity’, ‘long term side effects’ and ‘lack of trust in authorities’. One of the participants (P8) even mentioned that this whole vaccination drive may be scripted. There’s just not enough information to know. (P17) During that the time frame, that started like 2 months back, it is very short time to comment on that actual efficacy of the vaccine. (P9) Some participants were also critical with regards to the fast-tracking of vaccine compromising on the quality standards. I hope the quality standards would have been followed. I don’t know. But I think, fast-tracking was definitely necessary given the fact it’s a pandemic. (P11) Theme 6: vaccination policy The categories that emerged were that COVID-19 vaccination should not be made mandatory for all except for healthcare workers and the general public should be allowed to choose among the available COVID-19 vaccines. Earlier, in the vaccination drive, people were not allowed to choose between vaccines due to limited availability and logistical reasons. It is not supposed to be mandatory (P1) The public should have an option for it. For example the products, we should not force anyone to buy the product. (P8) Theme 7: cost of COVID-19 vaccine Many were of the opinion that making COVID-19 vaccine available ‘free of cost’ or at a ‘much lower rate’ would increase the vaccine uptake. One participant suggested that the cost be tier-based according to the economic status of the individual/family. For very poor people … it should be free of cost. (P10) I personally think the vaccine should be free for all (P11) Overall insights The study shows that many participants hold vaccines in high regard, seeing them as crucial for protecting against serious diseases. However, when it comes to the COVID-19 vaccine, opinions are more divided. Some people are ready to take the vaccine, trusting in its benefits, but others are hesitant, influenced by their own experiences, what they have heard from others and what the media has portrayed. While clear advice from doctors and encouragement from friends and family pushed some towards vaccination, others were put off by a lack of proper information, worries about how quickly the vaccine was developed and doubts about whether the authorities could be trusted. When it comes to policy, many participants felt that getting the vaccine should be a personal choice, not something that is forced on everyone. They also wanted the option to choose which vaccine to take, rather than being given no choice at all. Cost was a big concern too, with a strong preference for making the vaccine either free or affordable, especially for those who are less well-off. These insights highlight the need for open communication, building trust within the community and ensuring that vaccines are accessible to everyone, to increase confidence and willingness to get vaccinated. Figure 1 illustrates the triangulation of the qualitative findings, showing how the themes relate to one another and contribute to the overall insights on COVID-19 vaccination perceptions, Triangulation of the qualitative study results. Discussion This study provides insights into how individuals perceived and made decisions regarding COVID-19 vaccination during the peak of the second pandemic wave in India. The views of participants reflected a complex balance between personal risk perception, trust in authorities and exposure to evolving information through media and social networks. These findings highlight how contextual factors such as uncertainty, access and communication dynamics shape vaccine acceptance and hesitancy, aligning with prior evidence from India and other countries.6,8 The global response to COVID-19 saw varied vaccination acceptance across 23 countries, with increasing rates over time.14 The pandemic created global panic, making vaccines a crucial solution. Trust in doctors and friends, alongside social validation, social media, personal relationships and peer pressure, significantly influenced vaccination decisions. These findings align with those reported by Paul et al,15 Zimmermann et al16 and Larson et al.17 Lazarus et al14 have reported that 71.5% of participants would be willing to receive a vaccine if it were proven safe and effective. Encouragement from social and professional sources and the belief in immunisation as a social norm were key motivators. Longitudinal surveys also show that vaccine willingness can change over time. Our study highlights the crucial role of trust in healthcare agencies and government authorities in influencing vaccine acceptance, as supported by Salmon et al18 and Dong et al.19 It advocates for transparency in vaccination campaigns and the actions of government officials to enhance public confidence. Additionally, it highlights the role of social media in spreading accurate information about vaccines, scientific facts and preventive measures. Social media platforms host both accurate and false information, leading to vaccine hesitancy.20 All stakeholders, including the policy makers and social media influencers, should use evidence-based communication strategies to address concerns and bolster public confidence.21 The current study has brought out the various reasons behind vaccine hesitancy in Mumbai, particularly concerns about the rapid development and approval of COVID-19 vaccines, which raise questions about safety and long-term effects when compared with well-established vaccines like BCG and polio. This aligns with the findings of Cascini et al, where distrust in the vaccine development process plays a significant role.22 Our study also supports findings by Umakanthan et al20 that vaccine hesitancy in India is often driven by complacency, doubts about safety and effectiveness, and the inconvenience of accessing vaccines. Engaging trusted sources, spreading factual information and fostering open dialogue are vital to building public confidence, as highlighted by drawing on lessons from past public health challenges.23 There is a greater emphasis on the significance of affordability in promoting vaccine access and acceptance, similar to those by Dong et al19 and Larson et al.17 Participants emphasised the need for reasonably priced vaccines to ensure accessibility for the majority of the population. The call for free or lower-cost vaccines is driven by the belief that cost should not be a barrier to immunisation. The tier-based approach, as observed in some regions, recognises the varying economic capacities within the population and aims to ensure equitable vaccine access.24 The findings have implications for policymakers in shaping pricing strategies, promoting vaccine affordability and enhancing mass immunisation in metropolitan or urban areas. A key strength of the study is that it was conducted during the highly devastating second wave of COVID-19 in India, when many people were losing their lives and struggling to access hospital beds and medical oxygen. It captured real-time concerns about vaccine acceptance, including trust, safety fears and misinformation, which remain relevant today. Although the study was cross-sectional and did not follow participants longitudinally, it was undertaken during a period of rapidly evolving public sentiment. The perception of participants about vaccine safety, necessity and trust was likely shaped by this dynamic context, reflecting the prevailing uncertainty and heightened risk at that time. Hence, the findings should be interpreted in light of the temporal conditions under which the data were collected. Although the study was conducted in Mumbai, emerging evidence suggests that public sentiment during the second wave was highly similar across India, influenced by widespread media coverage and visible mortality throughout urban and rural regions.20 Limitations of the study include potential biases inherent in qualitative research, such as researcher subjectivity and participant self-reporting. Additionally, the study focused solely on perspectives of the general public not involved in COVID-19 care or research, which may limit the generalisability of the findings to other populations, such as healthcare workers. Conclusion This study highlights the pivotal role of trust and communication in vaccine acceptance, particularly within the Indian context. These findings reinforce broader evidence that such factors are universally important but may exert a greater influence in low-income and middle-income settings, where disparities in healthcare access, information transparency and public trust can amplify hesitancy and misinformation. Cautious attitudes of participants towards the COVID-19 vaccine, influenced by concerns about safety, rapid development and inconsistent information, underscore the need for transparent, culturally relevant public health strategies. In LMICs, where healthcare access is often limited, these findings stress the importance of making vaccines affordable and accessible. This study highlights the importance of building trust through transparent communication and respecting individual autonomy to enhance vaccine acceptance for future pandemics. These findings offer actionable strategies for policymakers to address public concerns effectively, ensuring broader and more equitable vaccine uptake. Supplementary material Acknowledgements The authors wish to acknowledge VeritasQ, Mumbai, for their support in qualitative data analysis and Medirite Research Trust, Tamil Nadu, India for their assistance in medical writing. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2025-103591). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Consent obtained directly from patient(s). Ethics approval: The study obtained approval from the Institutional Ethics Committee III - Seth GS Medical College and King Edward Memorial Hospital, under reference number EC/OA-20/2021, dated 3 March 2021. Participants gave informed consent to participate in the study before taking part. Data availability free text: The data used to support the findings of this study are available from the corresponding author upon request. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Data availability statement Data are available upon reasonable request. References Supplementary Materials Data Availability Statement Data are available upon reasonable request.